These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10912538)
21. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism. Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814 [TBL] [Abstract][Full Text] [Related]
22. Cardiac effect of vitamin D receptor modulators in uremic rats. Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785 [TBL] [Abstract][Full Text] [Related]
23. Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism. Salusky IB; Goodman WG; Kuizon BD Pediatr Nephrol; 2000 Jul; 14(7):641-5. PubMed ID: 10912534 [TBL] [Abstract][Full Text] [Related]
24. [Effect of growth hormone and calcitriol on the growth plate in uremic rats]. Amil B; Fernández-Fuente M; Santos F; Rodríguez J; Díaz-Tejón L; García E; Carbajo E Nefrologia; 2003; 23 Suppl 2():23-6. PubMed ID: 12778849 [TBL] [Abstract][Full Text] [Related]
25. Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. Gallieni M; Brancaccio D; Antonucci F; Bellinghieri G; Carpani P; Cozzolino M; D'Agostino F; Del Mastro G; Mallamace A; Memoli B Clin Nephrol; 2000 Mar; 53(3):188-93. PubMed ID: 10749297 [TBL] [Abstract][Full Text] [Related]
26. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats. Lopez I; Mendoza FJ; Guerrero F; Almaden Y; Henley C; Aguilera-Tejero E; Rodriguez M Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1376-85. PubMed ID: 19321594 [TBL] [Abstract][Full Text] [Related]
27. Modulation of endochondral bone formation: roles of growth hormone, 1,25-dihydroxyvitamin D and hyperparathyroidism. Sanchez CP Pediatr Nephrol; 2000 Jul; 14(7):646-9. PubMed ID: 10912535 [TBL] [Abstract][Full Text] [Related]
28. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Henley C; Colloton M; Cattley RC; Shatzen E; Towler DA; Lacey D; Martin D Nephrol Dial Transplant; 2005 Jul; 20(7):1370-7. PubMed ID: 15855208 [TBL] [Abstract][Full Text] [Related]
29. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797 [TBL] [Abstract][Full Text] [Related]
30. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia. Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908 [TBL] [Abstract][Full Text] [Related]
31. Growth hormone prevents steroid-induced growth depression in health and uremia. Kovàcs G; Fine RN; Worgall S; Schaefer F; Hunziker EB; Skottner-Lindun A; Mehls O Kidney Int; 1991 Dec; 40(6):1032-40. PubMed ID: 1762304 [TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial. Moe SM; Kraus MA; Gassensmith CM; Fineberg NS; Gannon FH; Peacock M Nephrol Dial Transplant; 1998 May; 13(5):1234-41. PubMed ID: 9623560 [TBL] [Abstract][Full Text] [Related]
33. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Lopez I; Mendoza FJ; Aguilera-Tejero E; Perez J; Guerrero F; Martin D; Rodriguez M Kidney Int; 2008 Feb; 73(3):300-7. PubMed ID: 18004298 [TBL] [Abstract][Full Text] [Related]
34. Vitamin E protects against extraskeletal calcification in uremic rats fed high fat diets. Rios R; Raya AI; Pineda C; Rodriguez M; Lopez I; Aguilera-Tejero E BMC Nephrol; 2017 Dec; 18(1):374. PubMed ID: 29281993 [TBL] [Abstract][Full Text] [Related]
35. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819 [TBL] [Abstract][Full Text] [Related]